These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21751487)

  • 1. [Drug promiscuity].
    Guo ZR
    Yao Xue Xue Bao; 2011 Apr; 46(4):361-9. PubMed ID: 21751487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein promiscuity: drug resistance and native functions--HIV-1 case.
    Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
    J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational application of drug promiscuity in medicinal chemistry.
    Mei Y; Yang B
    Future Med Chem; 2018 Aug; 10(15):1835-1851. PubMed ID: 30019924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
    Cerisier N; Petitjean M; Regad L; Bayard Q; Réau M; Badel A; Camproux AC
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ligand efficiency and lead optimization].
    Guo ZR
    Yao Xue Xue Bao; 2013 Dec; 48(12):1755-62. PubMed ID: 24689231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promiscuity in drug discovery on the verge of the structural revolution: recent advances and future chances.
    Bolz SN; Schroeder M
    Expert Opin Drug Discov; 2023; 18(9):973-985. PubMed ID: 37489516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting drug promiscuity using Gaussian ensemble screening.
    Pérez-Nueno VI; Venkatraman V; Mavridis L; Ritchie DW
    J Chem Inf Model; 2012 Aug; 52(8):1948-61. PubMed ID: 22747187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of molecular properties to drug promiscuity.
    Tarcsay Á; Keserű GM
    J Med Chem; 2013 Mar; 56(5):1789-95. PubMed ID: 23356819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein promiscuity in drug discovery, drug-repurposing and antibiotic resistance.
    Gupta MN; Alam A; Hasnain SE
    Biochimie; 2020 Aug; 175():50-57. PubMed ID: 32416199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we discover pharmacological promiscuity early in the drug discovery process?
    Peters JU; Hert J; Bissantz C; Hillebrecht A; Gerebtzoff G; Bendels S; Tillier F; Migeon J; Fischer H; Guba W; Kansy M
    Drug Discov Today; 2012 Apr; 17(7-8):325-35. PubMed ID: 22269136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promiscuity: what protects us, perplexes us.
    Redinbo MR
    Drug Discov Today; 2004 May; 9(10):431-2. PubMed ID: 15109946
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting ligand-gated ion channels in neurology and psychiatry: is pharmacological promiscuity an obstacle or an opportunity?
    Bianchi MT; Botzolakis EJ
    BMC Pharmacol; 2010 Mar; 10():3. PubMed ID: 20196850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling promiscuity based on in vitro safety pharmacology profiling data.
    Azzaoui K; Hamon J; Faller B; Whitebread S; Jacoby E; Bender A; Jenkins JL; Urban L
    ChemMedChem; 2007 Jun; 2(6):874-80. PubMed ID: 17492703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promiscuity of in Vitro Secondary Pharmacology Assays and Implications for Lead Optimization Strategies.
    Brown DG; Smith GF; Wobst HJ
    J Med Chem; 2020 Jun; 63(12):6251-6275. PubMed ID: 31714773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into molecular basis of cytochrome p450 inhibitory promiscuity of compounds.
    Cheng F; Yu Y; Zhou Y; Shen Z; Xiao W; Liu G; Li W; Lee PW; Tang Y
    J Chem Inf Model; 2011 Oct; 51(10):2482-95. PubMed ID: 21875141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IUPHAR-DB: updated database content and new features.
    Sharman JL; Benson HE; Pawson AJ; Lukito V; Mpamhanga CP; Bombail V; Davenport AP; Peters JA; Spedding M; Harmar AJ;
    Nucleic Acids Res; 2013 Jan; 41(Database issue):D1083-8. PubMed ID: 23087376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities.
    Seifert R; Dove S
    Mol Pharmacol; 2009 Jan; 75(1):13-8. PubMed ID: 19001067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity profile relationships between structurally similar promiscuous compounds.
    Hu Y; Bajorath J
    Eur J Med Chem; 2013 Nov; 69():393-8. PubMed ID: 24077530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strategy of molecular drug design: activity and druggability].
    Guo ZR
    Yao Xue Xue Bao; 2010 May; 45(5):539-47. PubMed ID: 20931752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.